AT370955T - N-sulfonylheterocyclopyrrolylalkylamin ligand compounds as 5-hydroxytryptamine. 6 - Google Patents

N-sulfonylheterocyclopyrrolylalkylamin ligand compounds as 5-hydroxytryptamine. 6

Info

Publication number
AT370955T
AT370955T AT04757294T AT04757294T AT370955T AT 370955 T AT370955 T AT 370955T AT 04757294 T AT04757294 T AT 04757294T AT 04757294 T AT04757294 T AT 04757294T AT 370955 T AT370955 T AT 370955T
Authority
AT
Austria
Prior art keywords
sulfonylheterocyclopyrrolylalkylamin
hydroxytryptamine
ligand compounds
ligand
compounds
Prior art date
Application number
AT04757294T
Other languages
German (de)
Inventor
Derek Cole
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US49162203P priority Critical
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AT370955T publication Critical patent/AT370955T/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
AT04757294T 2003-07-31 2004-07-23 N-sulfonylheterocyclopyrrolylalkylamin ligand compounds as 5-hydroxytryptamine. 6 AT370955T (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US49162203P true 2003-07-31 2003-07-31

Publications (1)

Publication Number Publication Date
AT370955T true AT370955T (en) 2007-09-15

Family

ID=34115532

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04757294T AT370955T (en) 2003-07-31 2004-07-23 N-sulfonylheterocyclopyrrolylalkylamin ligand compounds as 5-hydroxytryptamine. 6

Country Status (13)

Country Link
US (2) US7041695B2 (en)
EP (1) EP1648904B1 (en)
JP (1) JP2007500701A (en)
CN (1) CN100443487C (en)
AT (1) AT370955T (en)
AU (1) AU2004261606A1 (en)
BR (1) BRPI0413158A (en)
CA (1) CA2532382A1 (en)
DE (1) DE602004008474T2 (en)
DK (1) DK1648904T3 (en)
ES (1) ES2290740T3 (en)
MX (1) MXPA06000957A (en)
WO (1) WO2005012311A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT370955T (en) * 2003-07-31 2007-09-15 Wyeth Corp N-sulfonylheterocyclopyrrolylalkylamin ligand compounds as 5-hydroxytryptamine. 6
GB0403781D0 (en) * 2004-02-20 2004-03-24 Astrazeneca Ab Chemical compounds
US7314875B2 (en) * 2004-04-13 2008-01-01 Cephalon, Inc. Tricyclic aromatic and bis-phenyl sulfinyl derivatives
TW200800959A (en) * 2005-06-10 2008-01-01 Wyeth Corp Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
WO2006138549A1 (en) * 2005-06-17 2006-12-28 Wyeth Tricyclic compounds useful as serotonin inhibitors and 5-ht1a agonists and antagonists
TW200811144A (en) * 2006-06-09 2008-03-01 Wyeth Corp Crystalline forms of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline
TW200808741A (en) * 2006-06-09 2008-02-16 Wyeth Corp 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline hydrochloric acid salts
TW200808740A (en) * 2006-06-09 2008-02-16 Wyeth Corp Succinate salts of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline and crystalline forms thereof
AR063984A1 (en) * 2006-11-28 2009-03-04 Wyeth Corp Metabolites of 5-fluoro-8- {4- [4- (6-methoxy-8-yl) piperazin-1-yl] piperidin-1-yl} quinoline, methods of preparation, their use in the manufacture of medicaments for the treatment of disorders related to 5-HT1A pharmaceutical composition which comprises, radiolabeled compounds derived
TW200901974A (en) 2007-01-16 2009-01-16 Wyeth Corp Compounds, compositions, and methods of making and using them
EP2053052A1 (en) 2007-10-23 2009-04-29 Laboratorios del Dr. Esteve S.A. Process for the preparation of 6-substituted imidazo[2,1-b]thiazole-5-sulfonyl halide

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2537974B1 (en) * 1982-12-16 1985-03-15 Adir
GB9820113D0 (en) 1998-09-15 1998-11-11 Merck Sharp & Dohme Therapeutic agents
MXPA01005905A (en) * 1998-12-11 2002-09-18 Univ Virginia Commonwealth Selective 5-ht6.
GB0016454D0 (en) 2000-07-04 2000-08-23 Hoffmann La Roche Thienopyrrolidinones
US6730694B1 (en) 2001-07-20 2004-05-04 Eli Lilly And Company sPLA2 inhibitors
DE10063992A1 (en) 2000-12-21 2002-07-04 Max Planck Gesellschaft Tryptophan analogues into proteins, peptides and peptide lead compounds
BR0116481A (en) * 2000-12-22 2004-01-06 Wyeth Corp heterociclilalquilindol or azaindole compounds as 5-hydroxytryptamine-6 ​​ligands
DK1455779T3 (en) * 2001-12-20 2006-10-30 Wyeth Corp Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ​​ligands
JP2006508050A (en) * 2002-08-21 2006-03-09 アストラゼネカ アクチボラグ Thienopyrrole compounds as antagonists of gonadotropin-releasing hormone
TW200407127A (en) 2002-08-21 2004-05-16 Astrazeneca Ab Chemical compounds
AT370955T (en) * 2003-07-31 2007-09-15 Wyeth Corp N-sulfonylheterocyclopyrrolylalkylamin ligand compounds as 5-hydroxytryptamine. 6

Also Published As

Publication number Publication date
CN1826346A (en) 2006-08-30
WO2005012311A1 (en) 2005-02-10
CN100443487C (en) 2008-12-17
JP2007500701A (en) 2007-01-18
US20050038088A1 (en) 2005-02-17
BRPI0413158A (en) 2006-10-03
US7041695B2 (en) 2006-05-09
DK1648904T3 (en) 2007-10-22
ES2290740T3 (en) 2008-02-16
AU2004261606A1 (en) 2005-02-10
DE602004008474D1 (en) 2007-10-04
US20060160878A1 (en) 2006-07-20
EP1648904B1 (en) 2007-08-22
DE602004008474T2 (en) 2008-05-15
MXPA06000957A (en) 2006-03-30
EP1648904A1 (en) 2006-04-26
CA2532382A1 (en) 2005-02-10
US7220756B2 (en) 2007-05-22

Similar Documents

Publication Publication Date Title
DE60111734D1 (en) [1,4 '] - bipiperidin compounds
DE60135764D1 (en) Nitrogen-containing, five-membered ring compounds
FI20030958A0 (en) The new compounds
DE60234264D1 (en) Spiro-hydantoin compounds which are useful as anti-inflammatory agents
AT423113T (en) Substituted compounds oxoazaheterozyclische
DE602004005845D1 (en) Rotating leitungseinführer
DE602004028920D1 (en) By
NO20053933D0 (en) Machine for beverage preparation.
DE602004022819D1 (en) By ATP-binding cassette transporters
NO20060726L (en) Snuff-box lid
AT549329T (en) Chinazolines connections
DE602004027171D1 (en) Compounds with activity on the 11beta-Hydroxasteroiddehydrogenase
DE502004001070D1 (en) Carrier loader
DE60137734D1 (en) PyrroloÄ2,3-DÜpyrimidin compounds as immunosuppressive agents
DE60216115D1 (en) Benzimidazo 4.5-föISOCHINOLINON DERIVATIVES
SE0301569D0 (en) Novel compounds
DE60130338D1 (en) Chiral compounds II
DE60316468D1 (en) pyrimidine compounds
DE602004025641D1 (en) locking mechanism
NO20052993D0 (en) 4,5-diaryltiazolderivater as CB-1 ligands.
DE60228103D1 (en) Chemical compounds
DE60231202D1 (en) Condensed heterocyclic compounds
DE602004006169D1 (en) Substituted 8'-pyri (mi) dinyl-dihydrospiro-äcycloalkylaminü-6-one derivatives pyrimidoä1,2aüpyrimidin-
DE60106287D1 (en) Chemical compounds
DE60225341D1 (en) New 1,2,4-triazole compound

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties